Targeting delivery of liposomes with conjugated p-aminophenyl-α-d-manno-pyranoside and apolipoprotein E for inhibiting neuronal degeneration insulted with β-amyloid peptide

References

• Ivankin A, Kuzmenko I, Gidalevitz D. Cholesterol-phospholipid interactions: new insights from surface X-ray scattering data. Phys Rev Lett 2010;104:108101
   PubMed Web of Science ®Google Scholar
• Ohtake S, Schebor C, de Pablo JJ. Effects of trehalose on the phase behavior of DPPC-cholesterol unilamellar vesicles. Biochim Biophys Acta 2006;1758:65–73
   PubMed Web of Science ®Google Scholar
• Duzgunes N, Nir S. Mechanisms and kinetics of liposome-cell interactions. Adv Drug Deliv Rev 1999;40:3–18
   PubMed Web of Science ®Google Scholar
• Gosk S, Vermehren C, Storm G, Moos T. Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion. J Cereb Blood Flow Metab 2004;24:1193–204
   PubMed Web of Science ®Google Scholar
• Soni V, Kohli DV, Jain SK. Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil. J Drug Target 2005;13:245–50
   PubMed Web of Science ®Google Scholar
• Bu G. Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 2009;10:333–44
   PubMed Web of Science ®Google Scholar
• Ying X, Wen H, Lua WL, et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Rel 2010;141:183–92
   PubMed Web of Science ®Google Scholar
• West MJ, Kawas CH, Stewart WF, et al. Hippocampal neurons in pre-clinical Alzheimer’s disease. Neurobiol Aging 2004;25:1205–12
   PubMed Web of Science ®Google Scholar
• Deane R, Sagare A, Zlokovic B. The role of the cell surface LRP and soluble LRP in blood–brain barrier Aβ clearance in Alzheimer’s disease. Curr Pharm Des 2008;14:1601–5
   PubMed Web of Science ®Google Scholar
• Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002;297:353–6
   PubMed Web of Science ®Google Scholar
• Mufson EJ, Ginsberg SD, Ikonomovic MD, DeKosky ST. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat 2003;26:233–42
   PubMed Web of Science ®Google Scholar
• Wu CK, Thal L, Pizzo D, et al. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer’s disease. Exp Neurol 2005;195:484–96
   PubMed Web of Science ®Google Scholar
• Kelly JS. Alzheimer’s disease: the tacrine legacy. Trends Pharmacol Sci 1999;20:127–9
   PubMed Web of Science ®Google Scholar
• Frielingsdorf H, Simpson DR, Thal LJ, Pizzo DP. Nerve growth factor promotes survival of new neurons in the adult hippocampus. Neurobiol Dis 2007;26:47–55
   PubMed Web of Science ®Google Scholar
• Niewiadomska G, Mietelska-Porowska A, Mazurkiewicz M. The cholinergic system, nerve growth factor and the cytoskeleton. Behav Brain Res 2011;221:515–26
   PubMed Web of Science ®Google Scholar
• Kuo YC, Wang CT. Protection of SK-N-MC cells against β-amyloid peptide-induced degeneration using neuron growth factor-loaded liposomes with surface lactoferrin. Biomaterials 2014;35:5954–64
   PubMed Web of Science ®Google Scholar
• Kuo YC, Shih-Huang CY. Solid lipid nanoparticles with surface antibody for targeting the brain and inhibiting lymphatic phagocytosis. J Taiwan Inst Chem Eng 2014;45:1154–63
   Web of Science ®Google Scholar
• Kuo YC, Chou PR. Neuroprotection against degeneration of SK-N-MC cells using neuron growth factor-encapsulated liposomes with surface RMP-7 and transferring. J Pharm Sci 2014;103:2484–97
   PubMed Web of Science ®Google Scholar
• Kuo YC, Shih-Huang CY. Solid lipid nanoparticles carrying chemotherapeutic drug across the blood–brain barrier through insulin receptor-mediated pathway. J Drug Target 2013;21:730–8
   PubMed Web of Science ®Google Scholar
• Kuo YC, Yeh CF, Yang JT. Differentiation of bone marrow stromal cells in poly(lactide-co-glycolide)/chitosan scaffolds. Biomaterials 2009;30:6604–13
   PubMed Web of Science ®Google Scholar
• Kuo YC, Su FL. Transport of stavudine, delavirdine, and saquinavir across the blood–brain barrier by polybutylcyanoacrylate, methylmethacrylate–sulfopropylmethacrylate, and solid lipid nanoparticles. Int J Pharm 2007;340:143–52
   PubMed Web of Science ®Google Scholar
• Kuo YC, Lu CH. Effect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood–brain barrier. Colloids Surf B 2011;86:225–31
   PubMed Web of Science ®Google Scholar
• Kuo YC, Liu YC. Cardiolipin-incorporated liposomes with surface CRM197 for enhancing neuronal survival against neurotoxicity. Int J Pharm 2014;473:334–44
   Google Scholar
• Kuo YC, Hong TY. Delivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-moduline. Int J Pharm 2014;465:132–42
   PubMed Web of Science ®Google Scholar
• Chung CY, Yang JT, Kuo YC. Polybutylcyanoacrylate nanoparticle-mediated neurotrophin-3 gene delivery for differentiating iPS cells into neurons. Biomaterials 2013;34:5562–70
   PubMed Web of Science ®Google Scholar
• Kuo YC, Lu CH. Regulation of endocytosis into human brain-microvascular endothelial cells by inhibition of efflux proteins. Colloids Surf B 2011;87:139–45
   PubMed Web of Science ®Google Scholar
• Kuo YC, Ko HF. Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles. Biomaterials 2013;34:4818–30
   PubMed Web of Science ®Google Scholar
• Kuo YC, Wang CC. Cationic solid lipid nanoparticles with cholesterol-mediated surface layer for transporting saquinavir to the brain. Biotechnol Prog 2014;30:198–206
   PubMed Web of Science ®Google Scholar
• Kuo YC, Lu CH. Modulation of efflux proteins by electromagnetic field for delivering azidothymidine and saquinavir into the brain. Colloids Surf B 2012;91:291–5
   PubMed Web of Science ®Google Scholar
• Chung CY, Yang JT, Kuo YC. Polybutylcyanoacrylate nanoparticles for delivering hormone response element-conjugated neurotrophin-3 to the brain of intracerebral hemorrhagic rats. Biomaterials 2013;34:9717–27
   PubMed Web of Science ®Google Scholar
• Hicks CR, Turner KV. Fundamental concepts in the design of experiments. 5th ed. New York: Oxford University Press; 1999
   Google Scholar
• Hao Z, Cui Y, Li M, et al. Liposomes modified with P-aminophenyl-α-d-mannopyranoside: a carrier for targeting cerebral functional regions in mice. Eur J Pharm Biopharm 2013;84:505–16
   PubMed Web of Science ®Google Scholar
• Re F, Cambianica I, Zona C, et al. Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood–brain barrier model. Nanomedicine 2011;7:551–9
   PubMed Web of Science ®Google Scholar
• Kuo YC, Yu HW. Expression of ornithine decarboxylase during the transport of saquinavir across the blood–brain barrier using composite polymeric nanocarriers under an electromagnetic field. Colloids Surf B 2011;88:627–34
   PubMed Web of Science ®Google Scholar
• Muhonen J, Holopainen JM, Wiedmer SK. Interactions between local anesthetics and lipid dispersions studied with liposome electrokinetic capillary chromatography. J Chromatogr A 2009;1216:3392–7
   PubMed Web of Science ®Google Scholar
• Jiang W, Kim BYS, Rutka JT, Chan WCW. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 2008;3:145–50
   PubMed Web of Science ®Google Scholar
• Lu F, Wu SH, Hung Y, Mou CY. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 2009;5:1408–13
   PubMed Web of Science ®Google Scholar
• Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006;6:662–8
   PubMed Web of Science ®Google Scholar
• Weissleder R, Kelly K, Sun EY, et al. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotech 2005;23:1418–23
   PubMed Web of Science ®Google Scholar
• Tamaru M, Akita H, Kajimoto K, et al. An apolipoprotein E modified liposomal nanoparticle: ligand dependent efficiency as a siRNA delivery carrier for mouse-derived brain endothelial cells. Int J Pharm 2014;465:77–82
   PubMed Web of Science ®Google Scholar
• Woodle MC, Lasic DD. Sterically stabilized liposomes. Biochim Biophys Acta 1992;1113:171–99
   PubMed Web of Science ®Google Scholar
• Guo X, Szoka Jr FC. Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG-diortho ester–lipid conjugate. Bioconjug Chem 2001;12:291–300
   PubMed Web of Science ®Google Scholar
• Ramana LN, Sethuraman S, Ranga U, Krishnan UM. Development of a liposomal nanodelivery system for nevirapine. J Biomed Sci 2010;17:57
   PubMed Web of Science ®Google Scholar
• Nie Y, Ji L, Ding H, et al. Cholesterol derivatives based charged liposomes for doxorubicin delivery preparation, in vitro and in vivo characterization. Theranostics 2012;2:1092–103
   PubMed Web of Science ®Google Scholar
• Meenach SA, Vogt FG, Anderson KW, et al. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable DPPC and DPPC:DPPE-PEG microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols. Int J Nanomedicine 2013;8:275–93
   PubMed Web of Science ®Google Scholar
• Xie Y, Ye L, Zhang X, et al. Transport of nerve growth factor encapsulated into liposomes across the blood–brain barrier: in vitro and in vivo studies. J Control Rel 2005;105:106–19
   PubMed Web of Science ®Google Scholar
• Shimoji M, Imaizumi N, Aniya Y. Modulation of membrane-bound glutathione transferase activity by phospholipids including cardiolipin. Biol Pharm Bull 2011;34:209–13
   PubMed Web of Science ®Google Scholar
• Mitra M, Mandal AK, Chatterjee TK, Das N. Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis. J Drug Target 2005;13:285–93
   PubMed Web of Science ®Google Scholar
• Sancini G, Gregori M, Salvati E, et al. Functionalization with TAT-peptide enhances blood–brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide. J Nanomed Nanotechol 2013;4:1000171
   Google Scholar
• Hong D, Vidya S, Marisela A, et al. Enhanced blood–brain barrier transmigration using a novel transferrin embedded fluorescent magnetoliposome nanoformulation. Nanotechnology 2014;25:055101
   Web of Science ®Google Scholar
• Li G, Simon MJ, Cancel LM, et al. Permeability of endothelial and astrocyte cocultures: in vitro blood–brain barrier models for drug delivery studies. Ann Biomed Eng 2010;38:2499–511
   PubMed Web of Science ®Google Scholar
• Nishitsuji K, Hosono T, Nakamura T, et al. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood–brain barrier model. J Biochem 2011;286:17536–42
   Google Scholar
• Kuo YC, Wang LJ. Transferrin-grafted catanionic solid lipid nanoparticles for targeting delivery of saquinavir to the brain. J Taiwan Inst Chem Eng 2014;45:755–63
   Web of Science ®Google Scholar
• Trickler WJ, Lantz SM, Murdock RC, et al. Silver nanoparticle induced blood–brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol Sci 2010;118:160–70
   PubMed Web of Science ®Google Scholar
• Nishioka T, Oda Y, Seino Y, et al. Distribution of the glucose transporters in human brain tumors. Cancer Res 1992;52:3972–9
   PubMed Web of Science ®Google Scholar
• Zeller K, Rahner-Welsch S, Kuschinsky W. Distribution of Glut1 glucose transporters in different brain structures compared to glucose utilization and capillary density of adult rat brains. J Cereb Blood Flow 1997;17:204–9
   PubMed Web of Science ®Google Scholar
• Vannucci SJ, Maher F, Simpson IA. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 1997;21:2–21
   PubMed Web of Science ®Google Scholar
• Sarkar S, Das N. Mannosylated liposomal flavonoid in combating age-related ischemia-reperfusion induced oxidative damage in rat brain. Mech Age Dev 2006;127:391–7
   PubMed Web of Science ®Google Scholar
• Dehouck B, Fenart L, Dehouck MP, et al. A new function for the LDL receptor: transcytosis of LDL across the blood–brain barrier. J Cell Biol 1997;138:877–89
   PubMed Web of Science ®Google Scholar
• Kuo YC, Lin PI, Wang CC. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles. Nanomedicine 2011;6:1011–26
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Drug targeting to the brain. Pharm Res 2007;24:1733–44
   PubMed Web of Science ®Google Scholar
• Hefti F. Is Alzheimer disease caused by lack of nerve growth factor? Ann Neurol 1983;13:109–10
   PubMed Web of Science ®Google Scholar
• Longo FM, Vu TKH, Mobley WC. The in vitro biological effect of nerve growth factor is inhibited by synthetic peptides. Cell Regul 1990;1:189–95
   PubMedGoogle Scholar
• Nii T, Ishii F. Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. J Agric Food Chem 2005;298:198–205
   Google Scholar
• Lin CH, Al-Suwayeh SA, Hung CF, et al. Camptothecin-loaded liposomes with α-melanocyte-stimulating hormone enhance cytotoxicity toward and cellular uptake by melanomas: an application of nanomedicine on natural product. J Tradit Complement Med 2013;3:102–9
   PubMedGoogle Scholar
• Re F, Gobbi M, Salmona M, et al. Preparation and characterization of lipid-based nanoparticles binding with high affinity amyloid-β1–42 peptide. J Biotechnol 2010;150:27
   Web of Science ®Google Scholar
• Shaykhalishahi H, Taghizadeh M, Yazdanparast R, Chang YT. Anti-amyloidogenic effect of AA3E2 attenuates beta-amyloid induced toxicity in SK-N-MC cells. Chem Biol Interact 2010;186:16–23
   PubMed Web of Science ®Google Scholar
• Dalhoff A. Differences between bacteria grown in vitro and in vivo. J Antimicrob Chemother 1985;15:175–95
   PubMed Web of Science ®Google Scholar
• Lorian V. Differences between in vitro and in vivo studies. Antimicrob Agents Chemother 1988;32:1600–1
   PubMed Web of Science ®Google Scholar
• Smith MJ, Walker JR. The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leukocyte chemokinesis. Br J Pharmacol 1980;69:473–8
   PubMed Web of Science ®Google Scholar
• Shah PM. Activity of imipenem in an in vitro model simulating pharmacokinetic parameters in human blood. J Antimicrob Chemother 1985;15:153–7
   PubMed Web of Science ®Google Scholar
• Seeberg AH, Wiedemann B. Application of in vitro models: development of resistance. J Antimicrob Chemother 1985;15:241–9
   PubMed Web of Science ®Google Scholar
• Salvati E, Re F, Sesana S, et al. Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model. Int J Nanomedicine 2013;8:1749–58
   PubMed Web of Science ®Google Scholar
• Nagele RG, D’Andrea MR, Anderson WJ, Wang HY. Intracellular accumulation of β-amyloid in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer’s disease. Neuroscience 2002;110:199–211
   PubMed Web of Science ®Google Scholar